Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.
Also called NCT04927949
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 128 participants
- Sponsor
- Registry
-
NCT04927949
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT04927949. Randomized; no masking; primary purpose treatment. Start 2021-06-08 (actual); primary completion 2023-03-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not
- Acronym
- ERMIT
- Condition
- ST-elevation Myocardial Infarction
- Intervention (Drug)
- cangrelor perfusion during PCI (percutaneous coronary intervention)
- Intervention (Procedure)
- standard PCI
- Lead sponsor
- University Hospital, Caen
- Collaborator
- Terumo Medical Corporation
Record details
- Record id
cardio:ct-nct04927949- Content hash
d95ebb77747205ff195c97dc01a9f14e701f2417c79594b01cf521a3aca34f4c